A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease.
作者信息
Steinbrenner Inga, Yu Zhi, Jin Jin, Schultheiss Ulla T, Kotsis Fruzsina, Grams Morgan E, Coresh Josef, Wuttke Matthias, Kronenberg Florian, Eckardt Kai-Uwe, Chatterjee Nilanjan, Sekula Peggy, Köttgen Anna
机构信息
Institute of Genetic Epidemiology, Department of Data Driven Medicine, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
出版信息
Kidney Int. 2023 Feb;103(2):421-424. doi: 10.1016/j.kint.2022.11.013. Epub 2022 Dec 5.
Abstract
摘要
相似文献
1
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease.
Kidney Int. 2023 Feb;103(2):421-424. doi: 10.1016/j.kint.2022.11.013. Epub 2022 Dec 5.
2
Cross-ancestry genome-wide polygenic score predicts chronic kidney disease.
Nat Med. 2022 Jul;28(7):1355-1356. doi: 10.1038/s41591-022-01871-7.
3
Monogenic and polygenic concepts in chronic kidney disease (CKD).
J Nephrol. 2024 Jan;37(1):7-21. doi: 10.1007/s40620-023-01804-8. Epub 2023 Nov 21.
4
A polygenic score predicts CKD across ancestries.
Nat Rev Nephrol. 2022 Nov;18(11):681-682. doi: 10.1038/s41581-022-00622-8.
5
Genome-wide polygenic score to predict chronic kidney disease across ancestries.
Nat Med. 2022 Jul;28(7):1412-1420. doi: 10.1038/s41591-022-01869-1. Epub 2022 Jun 16.
6
Polygenic risk alters the penetrance of monogenic kidney disease.
Nat Commun. 2023 Dec 14;14(1):8318. doi: 10.1038/s41467-023-43878-9.
7
Polygenic scores and their applications in kidney disease.
Nat Rev Nephrol. 2025 Jan;21(1):24-38. doi: 10.1038/s41581-024-00886-2. Epub 2024 Sep 13.
8
Refining ASCVD risk prediction and temporal trends: the role of chronic kidney disease, polygenic risk scores, and longitudinal studies.
Eur J Prev Cardiol. 2023 May 9;30(7):e39-e40. doi: 10.1093/eurjpc/zwad014.
9
Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score.
Kidney Int. 2022 Nov;102(5):954-955. doi: 10.1016/j.kint.2022.08.004. Epub 2022 Aug 17.
10
Genome-wide study investigating effector genes and polygenic prediction for kidney function in persons with ancestry from Africa and the Americas.
Cell Genom. 2024 Jan 10;4(1):100468. doi: 10.1016/j.xgen.2023.100468. Epub 2023 Dec 22.
引用本文的文献
1
Polygenic scores and their applications in kidney disease.
Nat Rev Nephrol. 2025 Jan;21(1):24-38. doi: 10.1038/s41581-024-00886-2. Epub 2024 Sep 13.
2
Single-Ancestry versus Multi-Ancestry Polygenic Risk Scores for CKD in Black American Populations.
J Am Soc Nephrol. 2024 Nov 1;35(11):1558-1569. doi: 10.1681/ASN.0000000000000437. Epub 2024 Jul 29.
3
Familial Variability of Disease Severity in Adult Patients With ADPKD.
Kidney Int Rep. 2023 Dec 12;9(3):649-660. doi: 10.1016/j.ekir.2023.12.002. eCollection 2024 Mar.
4
Exploring the impact and utility of genomic sequencing in established CKD.
Clin Kidney J. 2024 Feb 21;17(3):sfae043. doi: 10.1093/ckj/sfae043. eCollection 2024 Mar.
5
Monogenic and polygenic concepts in chronic kidney disease (CKD).
J Nephrol. 2024 Jan;37(1):7-21. doi: 10.1007/s40620-023-01804-8. Epub 2023 Nov 21.
本文引用的文献
1
Genome-wide polygenic score to predict chronic kidney disease across ancestries.
Nat Med. 2022 Jul;28(7):1412-1420. doi: 10.1038/s41591-022-01869-1. Epub 2022 Jun 16.
2
Polygenic Risk Scores for Kidney Function and Their Associations with Circulating Proteome, and Incident Kidney Diseases.
J Am Soc Nephrol. 2021 Dec 1;32(12):3161-3173. doi: 10.1681/ASN.2020111599.
3
The illusion of polygenic disease risk prediction.
Genet Med. 2019 Aug;21(8):1705-1707. doi: 10.1038/s41436-018-0418-5. Epub 2019 Jan 12.
4
Genome-wide polygenic risk predictors for kidney disease.
Nat Rev Nephrol. 2018 Dec;14(12):723-724. doi: 10.1038/s41581-018-0067-6.
5
The personal and clinical utility of polygenic risk scores.
Nat Rev Genet. 2018 Sep;19(9):581-590. doi: 10.1038/s41576-018-0018-x.
6
Statistical controversies in clinical research: the importance of importance.
Ann Oncol. 2016 Jul;27(7):1185-9. doi: 10.1093/annonc/mdw159. Epub 2016 Apr 6.
7
Evolving importance of kidney disease: from subspecialty to global health burden.
Lancet. 2013 Jul 13;382(9887):158-69. doi: 10.1016/S0140-6736(13)60439-0. Epub 2013 May 31.
8
The German Chronic Kidney Disease (GCKD) study: design and methods.
Nephrol Dial Transplant. 2012 Apr;27(4):1454-60. doi: 10.1093/ndt/gfr456. Epub 2011 Aug 22.
Zotero 插件